International Flavors (IFF) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Core Insights - International Flavors (IFF) reported revenue of $2.93 billion for the quarter ended September 2024, reflecting a year-over-year increase of 3.7% [1] - Earnings per share (EPS) for the quarter was $1.04, up from $0.89 in the same quarter last year [1] - The reported revenue exceeded the Zacks Consensus Estimate of $2.83 billion by 3.25%, while the EPS fell short of the consensus estimate of $1.06 by 1.89% [1] Revenue Performance by Segment - Net Sales in the Nourish segment reached $1.49 billion, surpassing the average estimate of $1.44 billion, marking a 2.6% increase year-over-year [3] - Net Sales in the Scent segment were $613 million, slightly below the estimated $629.75 million, representing a minor decline of 0.3% compared to the previous year [3] - Net Sales in Pharma Solutions amounted to $256 million, exceeding the average estimate of $240.35 million, with a year-over-year growth of 7.6% [3] - Net Sales in Health & Biosciences reached $570 million, surpassing the estimated $531.83 million, reflecting a significant increase of 10% year-over-year [3] Adjusted Operating EBITDA Performance - Adjusted Operating EBITDA for the Nourish segment was $206 million, slightly below the estimate of $207.69 million [3] - Adjusted Operating EBITDA for Pharma Solutions was $62 million, exceeding the average estimate of $47.74 million [3] - Adjusted Operating EBITDA for the Scent segment was $127 million, falling short of the estimated $137.51 million [3] - Adjusted Operating EBITDA for Health & Biosciences was $173 million, surpassing the average estimate of $155.24 million [3] Stock Performance - Shares of International Flavors have returned -1.8% over the past month, compared to a -0.5% change in the Zacks S&P 500 composite [4] - The stock currently holds a Zacks Rank 1 (Strong Buy), indicating potential for outperformance in the near term [4]